Chronic kinin blockade and effect of ramipril in renal adaptation to sodium restriction

Hypertension

Volumn 27, Issue 1, 1996, Pages 79-84

  Jover, Bernard ^a   Hérizi, Abderraouf ^a   Mimran, Albert ^a  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

Author keywords

angiotensin converting enzyme inhibitors; bradykinin; receptors, angiotensin; renal circulation

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN I; BRADYKININ; BRADYKININ B2 RECEPTOR ANTAGONIST; ICATIBANT; KININ; LOSARTAN POTASSIUM; RAMIPRIL; SODIUM;

ADAPTATION; ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; DEPRESSOR RESPONSE; GLOMERULUS FILTRATION RATE; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM EXCRETION; SODIUM RESTRICTION; SUBCUTANEOUS DRUG ADMINISTRATION; VASODILATATION;

EID: 0030049301     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.27.1.79     Document Type: Article

References (33)

1. Jover B, Dupont M, Mimran A. Effects of perindopril on the renal hemodynamic changes associated with sodium restriction in the rat. J Hypertens. 1988;6(suppl 3):75-77.
2. Mimran A, Jover B, Dupont M. Enalapril-induced disturbance in the renal adaptation to sodium restriction in the rat. Kidney Int. 1988;34(suppl 25):28-32.
3. Gräfe M, Bossalier C, Graf K, Auch-Schwelk W, Baumgarten CR, Hildebrandt A, Fleck E. Effect of angiotensin-converting enzyme inhibition on bradykinin metabolism by vascular endothelial cells. Am J Physiol. 1993;264:H1493-H1497.
4. Hecker M, Pörsti I, Bara AT, Busse R. Potentiation by ACE inhibitors of the dilator response to bradykinin in the coronary microcirculation; interaction at the receptor level. Br J Pharmacol. 1994;111:238-244.
5. Cachofeiro V, Sakakibara T, Nasjletti A. Kinins, nitric oxide, and the hypertensive effect of captopril and rumiprilat in hypertension. Hypertension. 1992;19:138-145.
6. Benetos A, Gavras H, Stewart JM, Vavrek RJ, Hatinoglou S, Gavras I. Vasodepressor role of endogenous bradykinin assessed by a bradykinin antagonist. Hypertension. 1989;8:971-974.
7. Bao G, Gohlke P, Unger T. Role of bradykinin in chronic antihypertensive actions of ramipril in different hypertension models. J Cardiovasc Pharmacol. 1992;20(suppl 9):96-99.
8. Jover B, Saladini D, Nafrialdi N, Dupont M, Mimran A. Effect of losartan and enalapril on the renal adaptation to sodium restriction in rat Am J Phiysiol. 1994;267:F281-F288.
9. Mimran A, Baudin G, Casellas D, Soulas D, Urinary kallikrein and changes in endogenous aldosterone in the rat. Eur J Clin Invest. 1977;7:497-502.
10. Weinberg M, Belknap S, Trebbin W, Solomon RJ. Effects of changing salt and water balance on renal kallikrein, kininogen and kinin. Kidney Int. 1987;31:836-841.
11. Hock FJ, Wirth K, Albus U, Linz W, Gerhards HJ, Wiemer G, Henke S, Breipohl G, Konig W, Knolle J, Scholkens BA. Hoe140: a new and long acting bradykinin antagonist: - in vitro studies. Br J Pharmacol. 1991;102:769-773.
12. Wirth K, Hock FJ, Albus U, Linz W, Alpermann HG, Anagnostopoulos H, Henke S, Breipohl G, König W, Knolle J, Schölkens BA. Hoe140: a new potent and long-acting bradykinin-antagonist - in vivo studies. Br J Pharmacol. 1991;102:774-777.
13. Wong PC, Price WA, Chiu AT, Duncia JV, Carini DJ, Wexler RR, Johnson AL, Timmermans PBMWM. Nonpeptide angiotensin II receptor antagonists, VIII: characterization of functional antagonism displayed by DuP753, an orally active antihypertensive agent. J Pharmacol Exp Ther. 1990;252:719-725.
14. Madeddu P, Anania V, Pinna-Parpaglia PP, Deniontis MP, Varoni MV, Fattaccio MC, Glorioso N. Chronic kinin receptor blockade induces hypertension in deoxycorticosterone-treated rats. Br J Pharmacol. 1993;108:651-657.
15. Tomiyama H, Kushiro T, Abeta H, Ishii T, Takahashi A, Furukawa L, Asagami T, Hino T, Saito F, Otsuka Y, Kuruniatani H, Kobayashi F, Kanmatsuse K, Kajiwara N. Kinins contribute to the improvement of insulin sensitivity during treatment with angiotensin converting enzyme inhibitor. Hypertension. 1994;23:450-455.
16. Mimran A, Casellas D, Dupont M. Indirect evidence against a role of the kinin system in the renal hemodynamic effect of captopril in the rat. Kidney Int. 1980;18:746-753.
17. Valentin JP, Ribstein J, Pussard E, Mimran A. Role of atrial peptide in the acute natriuretic response to uninephrectomy. Am J Physiol. 1990;258:F1054-F1060.
18. Menard J, Catt KJ. Measurement of the renin activity, concentration and substrate in rat plasma by radioimmunoassay of angiotensin I. Endocrinology. 1972;90:422-430.
19. Fenoy FJ, Scicli G, Carretero O, Roman RJ. Effect of an angiotensin II and kinin receptor antagonist on the renal hemodynamic response to captopril. Hypertension. 1991;17:1038-1044.
20. Chen K, Zimmerman BG. Comparison of renal hemodynamic effect of ramiprilat to captopril: possible role of kinins. J Pharmacol Exp Ther. 1994;270:491-497.
21. Madeddu P. Receptor antagonists of bradykinin: a new tool to study the cardiovascular effects of endogenous kinins. Pharmacol Res. 1993;28:107-128.
22. Podjarny E, Rathaus M, Pomeranz A, Shapira J, Magen H, Kariv N, Bernheim J. Prostanoids in renal failure induced by converting enzyme inhibition in sodium-depleted rats. Am J Physiol. 1988;254:F358-F363.
23. Navar LG, Jirakulsomchok D, Bell PD, Thomas CE, Huang WC. Influence of converting enzyme inhibition on renal hemodynamics and glomerular dynamics in sodium-restricted dogs. Hypertension. 1982;4:58-68.
24. Rogacz S, Hollenberg NK, Williams GH. Role of angiotensin II in the hormonal, renal, and electrolyte responses to sodium restriction. Hypertension. 1987;9:289-294.
25. Doig JK, MacFayden RJ, Sweet CS, Reid JL. Haemodynamic and renal responses to oral losartan potassium during salt depletion or salt repletion in normal human volunteers. J Cardiovasc Pharmacol. 1995;25:511-517.
26. Kon V, Fogo A, Ichikawa I. Bradykinin causes selective efferent arteriolar dilation during angiotensin I converting enzyme inhibition. Kidney Int. 1993;44:545-550.
27. Granger JP, Hall JE. Acute and chronic actions of bradykinin on renal function and arlerial pressure. Am J Physiol. 1985;248:F87-F92.
28. Siragy HM. Evidence that intrarenal bradykinin plays a role in regulation of renal function. Am J Physiol. 1993;265:E648-E654.
29. Edwards RM. Response of isolated renal urterioles to acctylcholine, dopamine, and bradykinin. Am J Physiol. 1985;248:F183-F189.
30. Dworkin LD, Ichikawa I, Brenner BM. Hormonal modulation of glomerular function. Am J Physiol. 1983;244:F95-F104.
31. Uehara Y, Hirawa N, Kawabata Y, Suzuki T, Ohshima N, Oka K, Ikeda T, Goto A, Toyo-oka T, Kizuki K, Omata M. Long-term infusion of kallikrein allenuales renal injury in Dahl salt-sensitive rats. Hypertension. 1994;24:770-778.
32. 2-receptors alters the adult cardiovascular phenotype in rats. Hypertension. 1995;25:453-459.
33. 2 receptors enhances the slow vasopressor response to angiotensin II. Hypertension. 1994;23:646-652.